The 3 analysts offering 12-month price forecasts for ARS Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 17.00 and a low estimate of 10.00. The median estimate represents a +96.91% increase from the last price of 7.11.
The current consensus among 3 polled investment analysts is to Buy stock in ARS Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date Mar 29
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.